Abstract:IntroductionIn addition to its direct proinflammatory activity, extracellular high mobility group box protein 1 (HMGB1) can strongly enhance the cytokine response evoked by other proinflammatory molecules, such as lipopolysaccharide (LPS), CpG-DNA and IL-1β, through the formation of complexes. Extracellular HMGB1 is abundant in arthritic joint tissue where it is suggested to promote inflammation as intra-articular injections of HMGB1 induce synovitis in mice and HMGB1 neutralizing therapy suppresses development of experimental arthritis. The aim of this study was to determine whether HMGB1 in complex with LPS, interleukin (IL)-1α or IL-1β has enhancing effects on the production of proinflammatory mediators by rheumatoid arthritis synovial fibroblasts (RASF) and osteoarthritis synovial fibroblasts (OASF). Furthermore, we examined the toll-like receptor (TLR) 4 and IL-1RI requirement for the cytokine-enhancing effects of the investigated HMGB1-ligand complexes.MethodsSynovial fibroblasts obtained from rheumatoid arthritis (RA) and osteoarthritis (OA) patients were stimulated with HMGB1 alone or in complex with LPS, IL-1α or IL-1β. Tumour necrosis factor (TNF) production was determined by enzyme-linked immunospot assay (ELISPOT) assessment. Levels of IL-10, IL-1-β, IL-6 and IL-8 were measured using Cytokine Bead Array and matrix metalloproteinase (MMP) 3 production was determined by ELISA.ResultsStimulation with HMGB1 in complex with LPS, IL-1α or IL-1β enhanced production of TNF, IL-6 and IL-8. HMGB1 in complex with IL-1β increased MMP production from both RASF and OASF. The cytokine production was inhibited by specific receptor blockade using detoxified LPS or IL-1 receptor antagonist, indicating that the synergistic effects were mediated through the partner ligand-reciprocal receptors TLR4 and IL-1RI, respectively.ConclusionsHMGB1 in complex with LPS, IL-1α or IL-1β boosted proinflammatory cytokine- and MMP production in synovial fibroblasts from RA and OA patients. A mechanism for the pathogenic role of HMGB1 in arthritis could thus be through enhancement of inflammatory and destructive mechanisms induced by other proinflammatory mediators present in the arthritic joint.

Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus.

Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus.

Aberrant T Cell Subsets and Cytokines Expression Profile in Systemic Lupus Erythematosus.

Study on the expression of high mobility group box chromosomal protein 1 in skin lesions in patients with lupus erythematosus

Elevated Plasma Level of HMGB1 is Associated with Disease Activity and Combined Alterations with IFN-alpha and TNF-alpha in Systemic Lupus Erythematosus

[Expression of High Mobility Group Box Chromosomal Protein 1 in Peripheral Blood of Patients with Rheumatoid Arthritis].

Hmgb1 Promotes Systemic Lupus Erythematosus by Enhancing Macrophage Inflammatory Response

Roles of High Mobility Group Box 1 and Its Receptors in Systemic Lupus Erythematosus

[Role of HMGB1 in Rheumatic Diseases].

Expression and clinical significance of HMGB1 and sRAGE in patients with systemic sclerosis

Activation of JAK-STAT1 Signal Transduction Pathway in Lesional Skin and Monocytes from Patients with Systemic Lupus Erythematosus.

Serum HMGB-1 released by ferroptosis and necroptosis as a novel potential biomarker for systemic lupus erythematosus

A Possible Role of HMGB1 in DNA Demethylation in CD4+T Cells from Patients with Systemic Lupus Erythematosus

Effects of plasmapheresis on serum levels of HMGB1 in patients with systemic lupus erythematosus

Expressions and Clinical Significance of Inducible Co-Stimulator and Inducible Co-Stimulator Ligand in Peripheral Blood of Patients with Systemic Lupus Erythematosus

Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE

Downregulated Expression of LBH Mrna in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus

High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis

Extracellular, but not intracellular HMGB1, facilitates self-DNA induced macrophage activation via promoting DNA accumulation in endosomes and contributes to the pathogenesis of lupus nephritis

High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts

Expression of high mobility group box-1 protein mRNA in patients with chronic hepatitis B and its clinical significance